by Brad N. Taylor, Ph.D. | Mar 9, 2023
CBM, Nucleus Biologics, and Stoic Bio have launched a collaborative partnership to expedite the sustainable development of CGT therapies. The Center for Breakthrough Medicine (CBM) is a contract development and manufacturing organization (CDMO) located within The...
by Brad N. Taylor, Ph.D. | Feb 16, 2023
The emergence of organ-specific 3D tissue culture technology is a scientific breakthrough that promises a new era of disease research and discovery. Organoids are complex, 3-dimensional collections of cells grown in culture to mimic the organization of human organs....
by Brad N. Taylor, Ph.D. | Jul 12, 2022
Scientists are invested in making the world a better place to live— so how do we address the fact that the pharmaceutical industry has a sustainability problem? Read below for steps you can take to green your lab. Today, the pharmaceutical sector emits more...
by Brad N. Taylor, Ph.D. | May 24, 2022
Nucleus Biologics, together with its spinoff company Stoic Bio, is reimagining cell culture media manufacturing to bring the pharmaceutical industry a system that can deliver custom media in a sustainable manner-all while lowering the total delivered cost. In our...
